Reference : Results and Lessons Learned from the sbv IMPROVER Metagenomics Diagnostics for Inflam...
Scientific journals : Article
Life sciences : Multidisciplinary, general & others
Human health sciences : Immunology & infectious disease
Human health sciences : Multidisciplinary, general & others
Systems Biomedicine
http://hdl.handle.net/10993/54803
Results and Lessons Learned from the sbv IMPROVER Metagenomics Diagnostics for Inflammatory Bowel Disease Challenge
English
Khachatryan, Lusine [> >]
Xiang, Yang [> >]
Ivanov, Artem [> >]
Glaab, Enrico mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Biomedical Data Science]
Graham, Garrett [> >]
Granata, Ilaria [> >]
Giordano, Maurizio [> >]
Maddalena, Lucia [> >]
Piccirillo, Marina [> >]
Manipur, Ichcha [> >]
Baruzzo, Giacomo [> >]
Cappellato, Marco [> >]
Avot, Batiste [> >]
Stan, Adrian [> >]
Battey, James [> >]
Lo Sasso, Giuseppe [> >]
Boue, Stephanie [> >]
Ivanov, Nikolai V. [> >]
Peitsch, Manuel C. [> >]
Hoeng, Julia [> >]
Falquet, Laurent [> >]
Di Camillo, Barbara [> >]
Guarracino, Mario [> >]
Ulyantsev, Vladimir [> >]
Sierro, Nicolas [> >]
Poussin, Carine [> >]
2023
Scientific Reports
Nature Publishing Group
in press
Yes
International
[en] Gut microbiota ; Inflammatory bowel disease ; Metagenomics ; Non-invasive diagnostics ; Diagnosis ; Crohn's Disease ; Ulcerative Colitis ; classification ; supervised ; machine learning
[en] A growing body of evidence links gut microbiota changes with inflammatory bowel disease (IBD), raising the potential benefit of exploiting metagenomics data for non-invasive IBD diagnostics. The sbv IMPROVER Metagenomics Diagnosis for Inflammatory Bowel Disease Challenge (MEDIC) investigated computational metagenomics methods for discriminating IBD and nonIBD subjects. Participants in this challenge were given independent training and test metagenomics data from IBD and nonIBD subjects, which could be wither either raw read data (sub-challenge 1, SC1) or processed taxonomy- and function-based profiles (sub-challenge 2, SC2). A total of 81 anonymized submissions were received between September 2019 and March 2020. Most participants’ predictions performed better than random predictions in classifying IBD vs nonIBD, Ulcerative Colitis (UC) vs nonIBD, and Crohn’s Disease (CD) vs nonIBD. However, discrimination between UC and CD remains challenging, with the classification quality similar to the set of random predictions. We analyzed the class prediction accuracy, the metagenomics features by the teams, and computational methods used. These results will be openly shared with the scientific community to help advance IBD research and illustrate the application of a range of computational methodologies for effective metagenomic classification.
Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Glaab Group)
Researchers ; Professionals ; Students
http://hdl.handle.net/10993/54803
10.1038/s41598-023-33050-0
https://doi.org/10.1038/s41598-023-33050-0
The original publication is available at: https://doi.org/10.1038/s41598-023-33050-0

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
s41598-023-33050-0.pdfPublisher postprint6.21 MBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.